Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Operating Income

LEMAITRE VASCULAR, INC. Operating Income

LEMAITRE VASCULAR, INC. (LMAT) reported Operating Income of $20.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-05

  • LEMAITRE VASCULAR, INC. operating income (loss) for the quarter ending 2026-06-30 was $20.40M, a 26.37% increase year-over-year.
  • LEMAITRE VASCULAR, INC. operating income (loss) for the quarter ending 2026-03-31 was $17.77M, a 40.78% increase year-over-year.
  • LEMAITRE VASCULAR, INC. operating income (loss) for the quarter ending 2025-12-31 was $18.83M, a 46.51% increase year-over-year.
  • LEMAITRE VASCULAR, INC. operating income (loss) for the quarter ending 2025-09-30 was $20.31M, a 54.49% increase year-over-year.
  • LEMAITRE VASCULAR, INC. operating income (loss) for fiscal 2025 was $67.91M, a 29.96% increase from fiscal 2024.
  • LEMAITRE VASCULAR, INC. operating income (loss) for fiscal 2024 was $52.26M, a 42.34% increase from fiscal 2023.
  • LEMAITRE VASCULAR, INC. operating income (loss) for fiscal 2023 was $36.71M, a 36.84% increase from fiscal 2022.
  • LEMAITRE VASCULAR, INC. operating income (loss) for fiscal 2022 was $26.83M, a 26.34% decline from fiscal 2021.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30$20.40M
10-Q · filed 2026-08-05
$38.17M
10-Q · filed 2026-08-05
$57.01M
derived: sum of 3 quarters · filed 2026-08-05
$77.32M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$17.77M
10-Q · filed 2026-05-06
$36.61M
derived: sum of 2 quarters · filed 2026-05-06
$56.92M
derived: sum of 3 quarters · filed 2026-05-06
$73.06M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$18.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$39.14M
derived: sum of 2 quarters · filed 2026-02-26
$55.29M
derived: sum of 3 quarters · filed 2026-08-05
$67.91M
10-K · filed 2026-02-26
2025-09-30$20.31M
10-Q · filed 2025-11-07
$36.45M
derived: sum of 2 quarters · filed 2026-08-05
$49.08M
10-Q · filed 2025-11-07
$61.93M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$16.14M
10-Q · filed 2026-08-05
$28.77M
10-Q · filed 2026-08-05
$41.62M
derived: sum of 3 quarters · filed 2026-08-05
$54.77M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$12.63M
10-Q · filed 2026-05-06
$25.48M
derived: sum of 2 quarters · filed 2026-05-06
$38.63M
derived: sum of 3 quarters · filed 2026-05-06
$53.01M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$12.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$26.00M
derived: sum of 2 quarters · filed 2026-02-26
$40.38M
derived: sum of 3 quarters · filed 2026-02-26
$52.26M
10-K · filed 2026-02-26
2024-09-30$13.15M
10-Q · filed 2025-11-07
$27.53M
derived: sum of 2 quarters · filed 2025-11-07
$39.40M
10-Q · filed 2025-11-07
$49.61M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$14.38M
10-Q · filed 2025-08-06
$26.25M
10-Q · filed 2025-08-06
$36.46M
derived: sum of 3 quarters · filed 2025-08-06
$45.64M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$11.87M
10-Q · filed 2025-05-08
$22.08M
derived: sum of 2 quarters · filed 2025-05-08
$31.26M
derived: sum of 3 quarters · filed 2025-05-08
$40.71M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$10.21M
10-K · filed 2024-02-29
$19.39M
derived: sum of 2 quarters · filed 2024-11-08
$28.84M
derived: sum of 3 quarters · filed 2024-11-08
$36.71M
10-K · filed 2026-02-26
2023-09-30$9.18M
10-Q · filed 2024-11-08
$18.63M
derived: sum of 2 quarters · filed 2024-11-08
$26.51M
10-Q · filed 2024-11-08
$33.47M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$9.45M
10-Q · filed 2024-08-08
$17.33M
10-Q · filed 2024-08-08
$24.29M
derived: sum of 3 quarters · filed 2024-08-08
$30.44M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$7.87M
10-Q · filed 2024-05-10
$14.84M
derived: sum of 2 quarters · filed 2024-05-10
$20.99M
derived: sum of 3 quarters · filed 2024-05-10
$26.77M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$6.97M
10-K · filed 2024-02-29
$13.12M
derived: sum of 2 quarters · filed 2024-02-29
$18.90M
derived: sum of 3 quarters · filed 2024-02-29
$26.83M
10-K · filed 2025-02-28
2022-09-30$6.15M
10-K · filed 2024-02-29
$11.93M
derived: sum of 2 quarters · filed 2024-02-29
$19.86M
10-Q · filed 2023-11-07
$28.16M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$5.78M
10-K · filed 2024-02-29
$13.71M
10-Q · filed 2023-08-08
$22.01M
derived: sum of 3 quarters · filed 2024-02-29
$31.09M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$7.93M
10-K · filed 2024-02-29
$16.23M
derived: sum of 2 quarters · filed 2024-02-29
$25.30M
derived: sum of 3 quarters · filed 2024-02-29
$36.41M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$8.30M
10-K · filed 2023-03-01
$17.37M
derived: sum of 2 quarters · filed 2023-03-01
$28.48M
derived: sum of 3 quarters · filed 2023-03-01
$36.42M
10-K · filed 2024-02-29
2021-09-30$9.07M
10-K · filed 2023-03-01
$20.18M
derived: sum of 2 quarters · filed 2023-03-01
$28.12M
10-Q · filed 2022-11-08
$37.67M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$11.11M
10-K · filed 2023-03-01
$19.05M
10-Q · filed 2022-08-05
$28.60M
derived: sum of 3 quarters · filed 2023-03-01
$38.61M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$7.95M
10-K · filed 2023-03-01
$17.49M
derived: sum of 2 quarters · filed 2023-03-01
$27.51M
derived: sum of 3 quarters · filed 2023-03-01
$32.38M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$9.54M
10-K · filed 2022-02-28
$19.56M
derived: sum of 2 quarters · filed 2022-02-28
$24.43M
derived: sum of 3 quarters · filed 2022-02-28
$28.79M
10-K · filed 2023-03-01
2020-09-30$10.02M
10-K · filed 2022-02-28
$14.89M
derived: sum of 2 quarters · filed 2022-02-28
$19.24M
10-Q · filed 2021-11-04
$24.17M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$4.87M
10-K · filed 2022-02-28
$9.22M
10-Q · filed 2021-08-05
$14.15M
derived: sum of 3 quarters · filed 2022-02-28
$20.06M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$4.35M
10-K · filed 2022-02-28
$9.28M
derived: sum of 2 quarters · filed 2022-02-28
$15.19M
derived: sum of 3 quarters · filed 2022-02-28
$21.10M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$4.93M
10-K · filed 2021-03-12
$10.83M
derived: sum of 2 quarters · filed 2021-03-12
$16.75M
derived: sum of 3 quarters · filed 2021-03-12
$21.18M
10-K · filed 2022-02-28
2019-09-30$5.91M
10-K · filed 2021-03-12
$11.82M
derived: sum of 2 quarters · filed 2021-03-12
$16.25M
10-Q · filed 2020-11-06
$23.45M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$5.92M
10-K · filed 2021-03-12
$10.35M
10-Q · filed 2020-08-06
$17.54M
derived: sum of 3 quarters · filed 2021-03-12
$22.16M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$4.43M
10-K · filed 2021-03-12
$11.63M
derived: sum of 2 quarters · filed 2021-03-12
$16.24M
derived: sum of 3 quarters · filed 2021-03-12
$27.78M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$7.19M
10-K · filed 2020-03-12
$11.81M
derived: sum of 2 quarters · filed 2020-03-12
$23.35M
derived: sum of 3 quarters · filed 2020-03-12
$28.21M
10-K · filed 2021-03-12
2018-09-30$4.61M
10-K · filed 2020-03-12
$16.15M
derived: sum of 2 quarters · filed 2020-03-12
$21.02M
10-Q · filed 2019-11-08
$27.34M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$11.54M
10-Q · filed 2018-08-06
$16.40M
10-Q · filed 2019-08-06
$22.72M
derived: sum of 3 quarters · filed 2020-03-12
$27.78M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$4.86M
10-K · filed 2020-03-12
$11.18M
derived: sum of 2 quarters · filed 2020-03-12
$16.24M
derived: sum of 3 quarters · filed 2020-03-12
$21.77M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$6.32M
10-K · filed 2019-03-11
$11.37M
derived: sum of 2 quarters · filed 2019-03-11
$16.91M
derived: sum of 3 quarters · filed 2019-03-11
$21.10M
10-K · filed 2020-03-12
2017-09-30$5.05M
10-K · filed 2019-03-11
$10.59M
derived: sum of 2 quarters · filed 2019-03-11
$14.78M
10-Q · filed 2018-11-02
$18.69M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30$5.54M
10-Q · filed 2018-08-06
$9.73M
10-Q · filed 2018-08-06
$13.64M
derived: sum of 3 quarters · filed 2019-03-11
$18.98M
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31$4.19M
10-K · filed 2019-03-11
$8.10M
derived: sum of 2 quarters · filed 2019-03-11
$13.45M
derived: sum of 3 quarters · filed 2019-03-11
$17.23M
derived: sum of 4 quarters · filed 2019-03-11
2016-12-31$3.91M
10-K · filed 2018-03-09
$9.25M
derived: sum of 2 quarters · filed 2018-03-09
$13.04M
derived: sum of 3 quarters · filed 2018-03-09
$16.34M
10-K · filed 2019-03-11
2016-09-30$5.34M
10-K · filed 2018-03-09
$9.13M
derived: sum of 2 quarters · filed 2018-03-09
$12.43M
10-Q · filed 2017-11-03
$15.52M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$3.78M
10-Q · filed 2017-08-03
$7.08M
10-Q · filed 2017-08-03
$10.17M
derived: sum of 3 quarters · filed 2018-03-09
$13.49M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$3.30M
10-K · filed 2018-03-09
$6.39M
derived: sum of 2 quarters · filed 2018-03-09
$9.71M
derived: sum of 3 quarters · filed 2018-03-09
$12.50M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$6.41M
derived: sum of 2 quarters · filed 2018-03-09
$9.20M
derived: sum of 3 quarters · filed 2018-03-09
$11.51M
10-K · filed 2018-03-09
2015-09-30$3.32M
10-Q · filed 2016-11-04
$6.12M
derived: sum of 2 quarters · filed 2016-11-04
$8.42M
10-Q · filed 2016-11-04
$11.16M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$2.79M
10-Q · filed 2016-08-05
$5.10M
10-Q · filed 2016-08-05
$7.84M
derived: sum of 3 quarters · filed 2017-03-09
$9.69M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$2.31M
10-Q · filed 2016-05-06
$5.05M
derived: sum of 2 quarters · filed 2017-03-09
$6.90M
derived: sum of 3 quarters · filed 2017-03-09
$8.88M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$2.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$4.59M
derived: sum of 2 quarters · filed 2017-03-09
$6.57M
derived: sum of 3 quarters · filed 2017-03-09
$6.34M
10-K · filed 2017-03-09
2014-09-30$1.85M
10-Q · filed 2015-11-06
$3.83M
derived: sum of 2 quarters · filed 2015-11-06
$3.60M
10-Q · filed 2015-11-06
$4.77M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$1.98M
10-Q · filed 2015-08-06
$1.75M
10-Q · filed 2015-08-06
$2.92M
derived: sum of 3 quarters · filed 2016-03-10
$3.70M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31-$231.00K
10-Q · filed 2015-05-07
$941.00K
derived: sum of 2 quarters · filed 2016-03-10
$1.72M
derived: sum of 3 quarters · filed 2016-03-10
$3.16M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$1.95M
derived: sum of 2 quarters · filed 2016-03-10
$3.40M
derived: sum of 3 quarters · filed 2016-03-10
$4.52M
10-K · filed 2016-03-10
2013-09-30$776.00K
10-Q · filed 2014-11-06
$2.22M
derived: sum of 2 quarters · filed 2014-11-06
$3.35M
10-Q · filed 2014-11-06
$4.28M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30$1.45M
10-Q · filed 2014-08-07
$2.57M
10-Q · filed 2014-08-07
$3.50M
derived: sum of 3 quarters · filed 2015-03-18
$4.50M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31$1.12M
10-Q · filed 2014-05-08
$2.05M
derived: sum of 2 quarters · filed 2015-03-18
$3.05M
derived: sum of 3 quarters · filed 2015-03-18
$4.51M
derived: sum of 4 quarters · filed 2015-03-18
2012-12-31$930.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
$1.93M
derived: sum of 2 quarters · filed 2015-03-18
$3.39M
derived: sum of 3 quarters · filed 2015-03-18
$4.24M
10-K · filed 2015-03-18
2012-09-30$1.00M
10-Q · filed 2013-11-07
$2.46M
derived: sum of 2 quarters · filed 2013-11-07
$3.31M
10-Q · filed 2013-11-07
$4.14M
derived: sum of 4 quarters · filed 2014-03-21
2012-06-30$1.46M
10-Q · filed 2013-08-09
$2.31M
10-Q · filed 2013-08-09
$3.14M
derived: sum of 3 quarters · filed 2014-03-21
$5.13M
derived: sum of 4 quarters · filed 2014-03-21
2012-03-31$854.00K
10-Q · filed 2013-05-08
$1.69M
derived: sum of 2 quarters · filed 2014-03-21
$3.68M
derived: sum of 3 quarters · filed 2014-03-21
$4.57M
derived: sum of 4 quarters · filed 2014-03-21
2011-12-31$832.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
$2.82M
derived: sum of 2 quarters · filed 2014-03-21
$3.72M
derived: sum of 3 quarters · filed 2014-03-21
$3.69M
10-K · filed 2014-03-21
2011-09-30$1.99M
10-Q · filed 2012-11-09
$2.89M
derived: sum of 2 quarters · filed 2012-11-09
$2.86M
10-Q · filed 2012-11-09
$1.56M
derived: sum of 4 quarters · filed 2013-03-27
2011-06-30$897.00K
10-Q · filed 2012-08-10
$867.00K
10-Q · filed 2012-08-10
-$428.00K
derived: sum of 3 quarters · filed 2013-03-27
$1.60M
derived: sum of 4 quarters · filed 2013-03-27
2011-03-31-$30.00K
10-Q · filed 2012-05-03
-$1.32M
derived: sum of 2 quarters · filed 2013-03-27
$707.00K
derived: sum of 3 quarters · filed 2013-03-27
$2.71M
derived: sum of 4 quarters · filed 2013-03-27
2010-12-31-$1.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27
$737.00K
derived: sum of 2 quarters · filed 2013-03-27
$2.75M
derived: sum of 3 quarters · filed 2013-03-27
$4.01M
10-K · filed 2013-03-27
2010-09-30$2.03M
10-Q · filed 2011-11-14
$4.04M
derived: sum of 2 quarters · filed 2011-11-14
$5.31M
10-Q · filed 2011-11-14
2010-06-30$2.01M
10-Q · filed 2011-08-12
$3.28M
10-Q · filed 2011-08-12
2009-12-31$1.95M
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77